NCT06500130View on ClinicalTrials.gov

Effects of Liraglutide on Body Surface Gastric Mapping

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 30, 2024

Primary Completion Date

October 30, 2024

Study Completion Date

November 30, 2024

Conditions
GastroparesisFunctional DyspepsiaChronic Nausea and Vomiting SyndromeHealthy
Interventions
DEVICE

Body Surface Gastric Mapping

All study participants will be in this group and will have a total of three body surface gastric mapping tests conducted, pre, during and post liraglutide.

Trial Locations (1)

1010

Alimetry Clinic, Auckland

Sponsors

Lead Sponsor

Alimetry
All Listed Sponsors
lead

Alimetry

INDUSTRY

NCT06500130 - Effects of Liraglutide on Body Surface Gastric Mapping | Biotech Hunter | Biotech Hunter